Wegovy May Elevate Rare Eye Stroke Risk, Study Finds
TL;DR Summary
A large look at FDA adverse-event data suggests Wegovy (high-dose semaglutide) has a rare link to NAION, an “eye stroke” that can cause sudden vision loss, with men at higher risk than women. Wegovy shows a stronger association than Ozempic, possibly due to rapid weight loss and blood‑pressure fluctuations, but the overall risk remains very small and more research is needed.
- What Is 'Eye Stroke'? Expert Explains The Rare Wegovy Risk ScienceAlert
- Ozempic and Wegovy users reveal harrowing dark side of ‘miracle’ weight-loss drugs The Independent
- Study Looks at Associations Between Semaglutide and Ischemic Optic Neuropathy Optometry Advisor
- Info on Link Between Ozempic and Vision Loss Will Be Presented During 'Science Day' in June 2026 AboutLawsuits.com
- Wegovy linked to nearly five-fold higher risk of ischemic optic neuropathy than Ozempic Association of Optometrists (AOP)
Reading Insights
Total Reads
1
Unique Readers
4
Time Saved
5 min
vs 6 min read
Condensed
95%
1,156 → 61 words
Want the full story? Read the original article
Read on ScienceAlert